EPCAM and neoplasm: Therefore, diagnostic and therapeutic anti-EpCAM antibodies have been generated, including those that are approved for detecting circulating tumor cells7–9, and further developed into therapeutic agents8 against solid tumors, including colon and breast cancers10,11.